Global Alcohol Addiction Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

  • receipt Report ID : 82458
  • calendar_today Published On: Apr, 2021
  • file_copy Pages: 156
  • list Pharmaceuticals and Healthcare
Buy @ $3500

The Alcohol Addiction Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Alcohol Addiction Therapeutics size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Alcohol Addiction Therapeutics market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

Alcohol Addiction Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

CM-1212

CTDP-002

A-705253

ABT-436

ADX-71441

Others

Market segment by Application, can be divided into

Hospital

Clinic

Others

Market segment by players, this report covers

AstraZeneca Plc

BioCorRx Inc

Bionex Pharmaceuticals LLC

Cerecor Inc

Chronos Therapeutics Ltd

Corcept Therapeutics Inc

Curemark LLC

Eli Lilly and Company

Ethypharm SA

H. Lundbeck A/S

Heptares Therapeutics Ltd

Indivior Plc

Kinnov Therapeutics SAS

Kyorin Pharmaceutical Co Ltd

Lohocla Research Corp

Montisera Ltd

Omeros Corp

Opiant Pharmaceuticals Inc

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:

Chapter 1, to describe Alcohol Addiction Therapeutics product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top players of Alcohol Addiction Therapeutics, with revenue, gross margin and global market share of Alcohol Addiction Therapeutics from 2019 to 2021.

Chapter 3, the Alcohol Addiction Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Alcohol Addiction Therapeutics market forecast, by regions, type and application, with revenue, from 2021 to 2026.

Chapter 11 and 12, to describe Alcohol Addiction Therapeutics research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Market Overview

1.1 Product Overview and Scope of Alcohol Addiction Therapeutics

1.2 Classification of Alcohol Addiction Therapeutics by Type

1.2.1 Overview: Global Alcohol Addiction Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026

1.2.2 Global Alcohol Addiction Therapeutics Revenue Market Share by Type in 2020

1.2.3 CM-1212

1.2.4 CTDP-002

1.2.5 A-705253

1.2.6 ABT-436

1.2.7 ADX-71441

1.2.8 Others

1.3 Global Alcohol Addiction Therapeutics Market by Application

1.3.1 Overview: Global Alcohol Addiction Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Global Alcohol Addiction Therapeutics Market Size & Forecast

1.5 Global Alcohol Addiction Therapeutics Market Size and Forecast by Region

1.5.1 Global Alcohol Addiction Therapeutics Market Size by Region: 2016 VS 2021 VS 2026

1.5.2 Global Alcohol Addiction Therapeutics Market Size by Region, (2016-2021)

1.5.3 North America Alcohol Addiction Therapeutics Market Size and Prospect (2016-2026)

1.5.4 Europe Alcohol Addiction Therapeutics Market Size and Prospect (2016-2026)

1.5.5 Asia-Pacific Alcohol Addiction Therapeutics Market Size and Prospect (2016-2026)

1.5.6 South America Alcohol Addiction Therapeutics Market Size and Prospect (2016-2026)

1.5.7 Middle East and Africa Alcohol Addiction Therapeutics Market Size and Prospect (2016-2026)

1.6 Market Drivers, Restraints and Trends

1.6.1 Alcohol Addiction Therapeutics Market Drivers

1.6.2 Alcohol Addiction Therapeutics Market Restraints

1.6.3 Alcohol Addiction Therapeutics Trends Analysis

2 Company Profiles

2.1 AstraZeneca Plc

2.1.1 AstraZeneca Plc Details

2.1.2 AstraZeneca Plc Major Business

2.1.3 AstraZeneca Plc Alcohol Addiction Therapeutics Product and Solutions

2.1.4 AstraZeneca Plc Alcohol Addiction Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.1.5 AstraZeneca Plc Recent Developments and Future Plans

2.2 BioCorRx Inc

2.2.1 BioCorRx Inc Details

2.2.2 BioCorRx Inc Major Business

2.2.3 BioCorRx Inc Alcohol Addiction Therapeutics Product and Solutions

2.2.4 BioCorRx Inc Alcohol Addiction Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.2.5 BioCorRx Inc Recent Developments and Future Plans

2.3 Bionex Pharmaceuticals LLC

2.3.1 Bionex Pharmaceuticals LLC Details

2.3.2 Bionex Pharmaceuticals LLC Major Business

2.3.3 Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Product and Solutions

2.3.4 Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.3.5 Bionex Pharmaceuticals LLC Recent Developments and Future Plans

2.4 Cerecor Inc

2.4.1 Cerecor Inc Details

2.4.2 Cerecor Inc Major Business

2.4.3 Cerecor Inc Alcohol Addiction Therapeutics Product and Solutions

2.4.4 Cerecor Inc Alcohol Addiction Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.4.5 Cerecor Inc Recent Developments and Future Plans

2.5 Chronos Therapeutics Ltd

2.5.1 Chronos Therapeutics Ltd Details

2.5.2 Chronos Therapeutics Ltd Major Business

2.5.3 Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Product and Solutions

2.5.4 Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.5.5 Chronos Therapeutics Ltd Recent Developments and Future Plans

2.6 Corcept Therapeutics Inc

2.6.1 Corcept Therapeutics Inc Details

2.6.2 Corcept Therapeutics Inc Major Business

2.6.3 Corcept Therapeutics Inc Alcohol Addiction Therapeutics Product and Solutions

2.6.4 Corcept Therapeutics Inc Alcohol Addiction Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.6.5 Corcept Therapeutics Inc Recent Developments and Future Plans

2.7 Curemark LLC

2.7.1 Curemark LLC Details

2.7.2 Curemark LLC Major Business

2.7.3 Curemark LLC Alcohol Addiction Therapeutics Product and Solutions

2.7.4 Curemark LLC Alcohol Addiction Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.7.5 Curemark LLC Recent Developments and Future Plans

2.8 Eli Lilly and Company

2.8.1 Eli Lilly and Company Details

2.8.2 Eli Lilly and Company Major Business

2.8.3 Eli Lilly and Company Alcohol Addiction Therapeutics Product and Solutions

2.8.4 Eli Lilly and Company Alcohol Addiction Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.8.5 Eli Lilly and Company Recent Developments and Future Plans

2.9 Ethypharm SA

2.9.1 Ethypharm SA Details

2.9.2 Ethypharm SA Major Business

2.9.3 Ethypharm SA Alcohol Addiction Therapeutics Product and Solutions

2.9.4 Ethypharm SA Alcohol Addiction Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.9.5 Ethypharm SA Recent Developments and Future Plans

2.10 H. Lundbeck A/S

2.10.1 H. Lundbeck A/S Details

2.10.2 H. Lundbeck A/S Major Business

2.10.3 H. Lundbeck A/S Alcohol Addiction Therapeutics Product and Solutions

2.10.4 H. Lundbeck A/S Alcohol Addiction Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.10.5 H. Lundbeck A/S Recent Developments and Future Plans

2.11 Heptares Therapeutics Ltd

2.11.1 Heptares Therapeutics Ltd Details

2.11.2 Heptares Therapeutics Ltd Major Business

2.11.3 Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Product and Solutions

2.11.4 Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.11.5 Heptares Therapeutics Ltd Recent Developments and Future Plans

2.12 Indivior Plc

2.12.1 Indivior Plc Details

2.12.2 Indivior Plc Major Business

2.12.3 Indivior Plc Alcohol Addiction Therapeutics Product and Solutions

2.12.4 Indivior Plc Alcohol Addiction Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.12.5 Indivior Plc Recent Developments and Future Plans

2.13 Kinnov Therapeutics SAS

2.13.1 Kinnov Therapeutics SAS Details

2.13.2 Kinnov Therapeutics SAS Major Business

2.13.3 Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Product and Solutions

2.13.4 Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.13.5 Kinnov Therapeutics SAS Recent Developments and Future Plans

2.14 Kyorin Pharmaceutical Co Ltd

2.14.1 Kyorin Pharmaceutical Co Ltd Details

2.14.2 Kyorin Pharmaceutical Co Ltd Major Business

2.14.3 Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Product and Solutions

2.14.4 Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.14.5 Kyorin Pharmaceutical Co Ltd Recent Developments and Future Plans

2.15 Lohocla Research Corp

2.15.1 Lohocla Research Corp Details

2.15.2 Lohocla Research Corp Major Business

2.15.3 Lohocla Research Corp Alcohol Addiction Therapeutics Product and Solutions

2.15.4 Lohocla Research Corp Alcohol Addiction Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.15.5 Lohocla Research Corp Recent Developments and Future Plans

2.16 Montisera Ltd

2.16.1 Montisera Ltd Details

2.16.2 Montisera Ltd Major Business

2.16.3 Montisera Ltd Alcohol Addiction Therapeutics Product and Solutions

2.16.4 Montisera Ltd Alcohol Addiction Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.16.5 Montisera Ltd Recent Developments and Future Plans

2.17 Omeros Corp

2.17.1 Omeros Corp Details

2.17.2 Omeros Corp Major Business

2.17.3 Omeros Corp Alcohol Addiction Therapeutics Product and Solutions

2.17.4 Omeros Corp Alcohol Addiction Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.17.5 Omeros Corp Recent Developments and Future Plans

2.18 Opiant Pharmaceuticals Inc

2.18.1 Opiant Pharmaceuticals Inc Details

2.18.2 Opiant Pharmaceuticals Inc Major Business

2.18.3 Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Product and Solutions

2.18.4 Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Revenue, Gross Margin and Market Share (2019-2021)

2.18.5 Opiant Pharmaceuticals Inc Recent Developments and Future Plans

3 Market Competition, by Players

3.1 Global Alcohol Addiction Therapeutics Revenue and Share by Players (2019-2021)

3.2 Market Concentration Rate

3.2.1 Top 3 Alcohol Addiction Therapeutics Players Market Share

3.2.2 Top 10 Alcohol Addiction Therapeutics Players Market Share

3.2.3 Market Competition Trend

3.3 Alcohol Addiction Therapeutics Players Head Office, Products and Services Provided

3.4 Mergers & Acquisitions

3.5 New Entrants and Expansion Plans

4 Market Size Segment by Type

4.1 Global Alcohol Addiction Therapeutics Revenue and Market Share by Type (2016-2021)

4.2 Global Alcohol Addiction Therapeutics Market Forecast by Type (2021-2026)

5 Market Size Segment by Application

5.1 Global Alcohol Addiction Therapeutics Revenue Market Share by Application (2016-2021)

5.2 Alcohol Addiction Therapeutics Market Forecast by Application (2021-2026)

6 North America by Country, by Type, and by Application

6.1 North America Alcohol Addiction Therapeutics Revenue by Type (2016-2026)

6.2 North America Alcohol Addiction Therapeutics Revenue by Application (2016-2026)

6.3 North America Alcohol Addiction Therapeutics Market Size by Country

6.3.1 North America Alcohol Addiction Therapeutics Revenue by Country (2016-2026)

6.3.2 United States Alcohol Addiction Therapeutics Market Size and Forecast (2016-2026)

6.3.3 Canada Alcohol Addiction Therapeutics Market Size and Forecast (2016-2026)

6.3.4 Mexico Alcohol Addiction Therapeutics Market Size and Forecast (2016-2026)

7 Europe by Country, by Type, and by Application

7.1 Europe Alcohol Addiction Therapeutics Revenue by Type (2016-2026)

7.2 Europe Alcohol Addiction Therapeutics Revenue by Application (2016-2026)

7.3 Europe Alcohol Addiction Therapeutics Market Size by Country

7.3.1 Europe Alcohol Addiction Therapeutics Revenue by Country (2016-2026)

7.3.2 Germany Alcohol Addiction Therapeutics Market Size and Forecast (2016-2026)

7.3.3 France Alcohol Addiction Therapeutics Market Size and Forecast (2016-2026)

7.3.4 United Kingdom Alcohol Addiction Therapeutics Market Size and Forecast (2016-2026)

7.3.5 Russia Alcohol Addiction Therapeutics Market Size and Forecast (2016-2026)

7.3.6 Italy Alcohol Addiction Therapeutics Market Size and Forecast (2016-2026)

8 Asia-Pacific by Region, by Type, and by Application

8.1 Asia-Pacific Alcohol Addiction Therapeutics Revenue by Type (2016-2026)

8.2 Asia-Pacific Alcohol Addiction Therapeutics Revenue by Application (2016-2026)

8.3 Asia-Pacific Alcohol Addiction Therapeutics Market Size by Region

8.3.1 Asia-Pacific Alcohol Addiction Therapeutics Revenue by Region (2016-2026)

8.3.2 China Alcohol Addiction Therapeutics Market Size and Forecast (2016-2026)

8.3.3 Japan Alcohol Addiction Therapeutics Market Size and Forecast (2016-2026)

8.3.4 South Korea Alcohol Addiction Therapeutics Market Size and Forecast (2016-2026)

8.3.5 India Alcohol Addiction Therapeutics Market Size and Forecast (2016-2026)

8.3.6 Southeast Asia Alcohol Addiction Therapeutics Market Size and Forecast (2016-2026)

8.3.7 Australia Alcohol Addiction Therapeutics Market Size and Forecast (2016-2026)

9 South America by Country, by Type, and by Application

9.1 South America Alcohol Addiction Therapeutics Revenue by Type (2016-2026)

9.2 South America Alcohol Addiction Therapeutics Revenue by Application (2016-2026)

9.3 South America Alcohol Addiction Therapeutics Market Size by Country

9.3.1 South America Alcohol Addiction Therapeutics Revenue by Country (2016-2026)

9.3.2 Brazil Alcohol Addiction Therapeutics Market Size and Forecast (2016-2026)

9.3.3 Argentina Alcohol Addiction Therapeutics Market Size and Forecast (2016-2026)

10 Middle East & Africa by Country, by Type, and by Application

10.1 Middle East & Africa Alcohol Addiction Therapeutics Revenue by Type (2016-2026)

10.2 Middle East & Africa Alcohol Addiction Therapeutics Revenue by Application (2016-2026)

10.3 Middle East & Africa Alcohol Addiction Therapeutics Market Size by Country

10.3.1 Middle East & Africa Alcohol Addiction Therapeutics Revenue by Country (2016-2026)

10.3.2 Turkey Alcohol Addiction Therapeutics Market Size and Forecast (2016-2026)

10.3.3 Saudi Arabia Alcohol Addiction Therapeutics Market Size and Forecast (2016-2026)

10.3.4 UAE Alcohol Addiction Therapeutics Market Size and Forecast (2016-2026)

11 Research Findings and Conclusion

12 Appendix

12.1 Methodology

12.2 Research Process and Data Source

12.3 Disclaimer

List of Tables

Table 1. Global Alcohol Addiction Therapeutics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026

Table 2. Global Alcohol Addiction Therapeutics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026

Table 3. Global Market Alcohol Addiction Therapeutics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)

Table 4. Global Alcohol Addiction Therapeutics Revenue (USD Million) by Region (2016-2021)

Table 5. Global Alcohol Addiction Therapeutics Revenue Market Share by Region (2021-2026)

Table 6. AstraZeneca Plc Corporate Information, Head Office, and Major Competitors

Table 7. AstraZeneca Plc Major Business

Table 8. AstraZeneca Plc Alcohol Addiction Therapeutics Product and Solutions

Table 9. AstraZeneca Plc Alcohol Addiction Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 10. BioCorRx Inc Corporate Information, Head Office, and Major Competitors

Table 11. BioCorRx Inc Major Business

Table 12. BioCorRx Inc Alcohol Addiction Therapeutics Product and Solutions

Table 13. BioCorRx Inc Alcohol Addiction Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 14. Bionex Pharmaceuticals LLC Corporate Information, Head Office, and Major Competitors

Table 15. Bionex Pharmaceuticals LLC Major Business

Table 16. Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Product and Solutions

Table 17. Bionex Pharmaceuticals LLC Alcohol Addiction Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 18. Cerecor Inc Corporate Information, Head Office, and Major Competitors

Table 19. Cerecor Inc Major Business

Table 20. Cerecor Inc Alcohol Addiction Therapeutics Product and Solutions

Table 21. Cerecor Inc Alcohol Addiction Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 22. Chronos Therapeutics Ltd Corporate Information, Head Office, and Major Competitors

Table 23. Chronos Therapeutics Ltd Major Business

Table 24. Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Product and Solutions

Table 25. Chronos Therapeutics Ltd Alcohol Addiction Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 26. Corcept Therapeutics Inc Corporate Information, Head Office, and Major Competitors

Table 27. Corcept Therapeutics Inc Major Business

Table 28. Corcept Therapeutics Inc Alcohol Addiction Therapeutics Product and Solutions

Table 29. Corcept Therapeutics Inc Alcohol Addiction Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 30. Curemark LLC Corporate Information, Head Office, and Major Competitors

Table 31. Curemark LLC Major Business

Table 32. Curemark LLC Alcohol Addiction Therapeutics Product and Solutions

Table 33. Curemark LLC Alcohol Addiction Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 34. Eli Lilly and Company Corporate Information, Head Office, and Major Competitors

Table 35. Eli Lilly and Company Major Business

Table 36. Eli Lilly and Company Alcohol Addiction Therapeutics Product and Solutions

Table 37. Eli Lilly and Company Alcohol Addiction Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 38. Ethypharm SA Corporate Information, Head Office, and Major Competitors

Table 39. Ethypharm SA Major Business

Table 40. Ethypharm SA Alcohol Addiction Therapeutics Product and Solutions

Table 41. Ethypharm SA Alcohol Addiction Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 42. H. Lundbeck A/S Corporate Information, Head Office, and Major Competitors

Table 43. H. Lundbeck A/S Major Business

Table 44. H. Lundbeck A/S Alcohol Addiction Therapeutics Product and Solutions

Table 45. H. Lundbeck A/S Alcohol Addiction Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 46. Heptares Therapeutics Ltd Corporate Information, Head Office, and Major Competitors

Table 47. Heptares Therapeutics Ltd Major Business

Table 48. Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Product and Solutions

Table 49. Heptares Therapeutics Ltd Alcohol Addiction Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 50. Indivior Plc Corporate Information, Head Office, and Major Competitors

Table 51. Indivior Plc Major Business

Table 52. Indivior Plc Alcohol Addiction Therapeutics Product and Solutions

Table 53. Indivior Plc Alcohol Addiction Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 54. Kinnov Therapeutics SAS Corporate Information, Head Office, and Major Competitors

Table 55. Kinnov Therapeutics SAS Major Business

Table 56. Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Product and Solutions

Table 57. Kinnov Therapeutics SAS Alcohol Addiction Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 58. Kyorin Pharmaceutical Co Ltd Corporate Information, Head Office, and Major Competitors

Table 59. Kyorin Pharmaceutical Co Ltd Major Business

Table 60. Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Product and Solutions

Table 61. Kyorin Pharmaceutical Co Ltd Alcohol Addiction Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 62. Lohocla Research Corp Corporate Information, Head Office, and Major Competitors

Table 63. Lohocla Research Corp Major Business

Table 64. Lohocla Research Corp Alcohol Addiction Therapeutics Product and Solutions

Table 65. Lohocla Research Corp Alcohol Addiction Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 66. Montisera Ltd Corporate Information, Head Office, and Major Competitors

Table 67. Montisera Ltd Major Business

Table 68. Montisera Ltd Alcohol Addiction Therapeutics Product and Solutions

Table 69. Montisera Ltd Alcohol Addiction Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 70. Omeros Corp Corporate Information, Head Office, and Major Competitors

Table 71. Omeros Corp Major Business

Table 72. Omeros Corp Alcohol Addiction Therapeutics Product and Solutions

Table 73. Omeros Corp Alcohol Addiction Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 74. Opiant Pharmaceuticals Inc Corporate Information, Head Office, and Major Competitors

Table 75. Opiant Pharmaceuticals Inc Major Business

Table 76. Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Product and Solutions

Table 77. Opiant Pharmaceuticals Inc Alcohol Addiction Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)

Table 78. Global Alcohol Addiction Therapeutics Revenue (USD Million) by Players (2019-2021)

Table 79. Global Alcohol Addiction Therapeutics Revenue Share by Players (2019-2021)

Table 80. Breakdown of Alcohol Addiction Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)

Table 81. Alcohol Addiction Therapeutics Players Head Office, Products and Services Provided

Table 82. Alcohol Addiction Therapeutics Mergers & Acquisitions in the Past Five Years

Table 83. Alcohol Addiction Therapeutics New Entrants and Expansion Plans

Table 84. Global Alcohol Addiction Therapeutics Revenue (USD Million) by Type (2016-2021)

Table 85. Global Alcohol Addiction Therapeutics Revenue Share by Type (2016-2021)

Table 86. Global Alcohol Addiction Therapeutics Revenue Forecast by Type (2021-2026)

Table 87. Global Alcohol Addiction Therapeutics Revenue by Application (2016-2021)

Table 88. Global Alcohol Addiction Therapeutics Revenue Forecast by Application (2021-2026)

Table 89. North America Alcohol Addiction Therapeutics Revenue by Type (2016-2021) & (USD Million)

Table 90. North America Alcohol Addiction Therapeutics Revenue by Type (2021-2026) & (USD Million)

Table 91. North America Alcohol Addiction Therapeutics Revenue by Application (2016-2021) & (USD Million)

Table 92. North America Alcohol Addiction Therapeutics Revenue by Application (2021-2026) & (USD Million)

Table 93. North America Alcohol Addiction Therapeutics Revenue by Country (2016-2021) & (USD Million)

Table 94. North America Alcohol Addiction Therapeutics Revenue by Country (2021-2026) & (USD Million)

Table 95. Europe Alcohol Addiction Therapeutics Revenue by Type (2016-2021) & (USD Million)

Table 96. Europe Alcohol Addiction Therapeutics Revenue by Type (2021-2026) & (USD Million)

Table 97. Europe Alcohol Addiction Therapeutics Revenue by Application (2016-2021) & (USD Million)

Table 98. Europe Alcohol Addiction Therapeutics Revenue by Application (2021-2026) & (USD Million)

Table 99. Europe Alcohol Addiction Therapeutics Revenue by Country (2016-2021) & (USD Million)

Table 100. Europe Alcohol Addiction Therapeutics Revenue by Country (2021-2026) & (USD Million)

Table 101. Asia-Pacific Alcohol Addiction Therapeutics Revenue by Type (2016-2021) & (USD Million)

Table 102. Asia-Pacific Alcohol Addiction Therapeutics Revenue by Type (2021-2026) & (USD Million)

Table 103. Asia-Pacific Alcohol Addiction Therapeutics Revenue by Application (2016-2021) & (USD Million)

Table 104. Asia-Pacific Alcohol Addiction Therapeutics Revenue by Application (2021-2026) & (USD Million)

Table 105. Asia-Pacific Alcohol Addiction Therapeutics Revenue by Region (2016-2021) & (USD Million)

Table 106. Asia-Pacific Alcohol Addiction Therapeutics Revenue by Region (2021-2026) & (USD Million)

Table 107. South America Alcohol Addiction Therapeutics Revenue by Type (2016-2021) & (USD Million)

Table 108. South America Alcohol Addiction Therapeutics Revenue by Type (2021-2026) & (USD Million)

Table 109. South America Alcohol Addiction Therapeutics Revenue by Application (2016-2021) & (USD Million)

Table 110. South America Alcohol Addiction Therapeutics Revenue by Application (2021-2026) & (USD Million)

Table 111. South America Alcohol Addiction Therapeutics Revenue by Country (2016-2021) & (USD Million)

Table 112. South America Alcohol Addiction Therapeutics Revenue by Country (2021-2026) & (USD Million)

Table 113. Middle East & Africa Alcohol Addiction Therapeutics Revenue by Type (2016-2021) & (USD Million)

Table 114. Middle East & Africa Alcohol Addiction Therapeutics Revenue by Type (2021-2026) & (USD Million)

Table 115. Middle East & Africa Alcohol Addiction Therapeutics Revenue by Application (2016-2021) & (USD Million)

Table 116. Middle East & Africa Alcohol Addiction Therapeutics Revenue by Application (2021-2026) & (USD Million)

Table 117. Middle East & Africa Alcohol Addiction Therapeutics Revenue by Country (2016-2021) & (USD Million)

Table 118. Middle East & Africa Alcohol Addiction Therapeutics Revenue by Country (2021-2026) & (USD Million)

List of Figures

Figure 1. Alcohol Addiction Therapeutics Picture

Figure 2. Global Alcohol Addiction Therapeutics Revenue Market Share by Type in 2020

Figure 3. CM-1212

Figure 4. CTDP-002

Figure 5. A-705253

Figure 6. ABT-436

Figure 7. ADX-71441

Figure 8. Others

Figure 9. Alcohol Addiction Therapeutics Revenue Market Share by Application in 2020

Figure 10. Hospital Picture

Figure 11. Clinic Picture

Figure 12. Others Picture

Figure 13. Global Alcohol Addiction Therapeutics Revenue, (USD Million): 2020 VS 2021 VS 2026

Figure 14. Global Alcohol Addiction Therapeutics Revenue and Forecast (2016-2026) & (USD Million)

Figure 15. Global Alcohol Addiction Therapeutics Revenue Market Share by Region (2016-2026)

Figure 16. Global Alcohol Addiction Therapeutics Revenue Market Share by Region in 2020

Figure 17. North America Alcohol Addiction Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 18. Europe Alcohol Addiction Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 19. Asia-Pacific Alcohol Addiction Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 20. South America Alcohol Addiction Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 21. Middle East and Africa Alcohol Addiction Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)

Figure 22. Alcohol Addiction Therapeutics Market Drivers

Figure 23. Alcohol Addiction Therapeutics Market Restraints

Figure 24. Alcohol Addiction Therapeutics Market Trends

Figure 25. AstraZeneca Plc Recent Developments and Future Plans

Figure 26. BioCorRx Inc Recent Developments and Future Plans

Figure 27. Bionex Pharmaceuticals LLC Recent Developments and Future Plans

Figure 28. Cerecor Inc Recent Developments and Future Plans

Figure 29. Chronos Therapeutics Ltd Recent Developments and Future Plans

Figure 30. Corcept Therapeutics Inc Recent Developments and Future Plans

Figure 31. Curemark LLC Recent Developments and Future Plans

Figure 32. Eli Lilly and Company Recent Developments and Future Plans

Figure 33. Ethypharm SA Recent Developments and Future Plans

Figure 34. H. Lundbeck A/S Recent Developments and Future Plans

Figure 35. Heptares Therapeutics Ltd Recent Developments and Future Plans

Figure 36. Indivior Plc Recent Developments and Future Plans

Figure 37. Kinnov Therapeutics SAS Recent Developments and Future Plans

Figure 38. Kyorin Pharmaceutical Co Ltd Recent Developments and Future Plans

Figure 39. Lohocla Research Corp Recent Developments and Future Plans

Figure 40. Montisera Ltd Recent Developments and Future Plans

Figure 41. Omeros Corp Recent Developments and Future Plans

Figure 42. Opiant Pharmaceuticals Inc Recent Developments and Future Plans

Figure 43. Global Alcohol Addiction Therapeutics Revenue Share by Players in 2020

Figure 44. Alcohol Addiction Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

Figure 45. Global Top 3 Players Alcohol Addiction Therapeutics Revenue Market Share in 2020

Figure 46. Global Top 10 Players Alcohol Addiction Therapeutics Revenue Market Share in 2020

Figure 47. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)

Figure 48. Global Alcohol Addiction Therapeutics Revenue Share by Type in 2020

Figure 49. Global Alcohol Addiction Therapeutics Market Share Forecast by Type (2021-2026)

Figure 50. Global Alcohol Addiction Therapeutics Revenue Share by Application in 2020

Figure 51. Global Alcohol Addiction Therapeutics Market Share Forecast by Application (2021-2026)

Figure 52. North America Alcohol Addiction Therapeutics Sales Market Share by Type (2016-2026)

Figure 53. North America Alcohol Addiction Therapeutics Sales Market Share by Application (2016-2026)

Figure 54. North America Alcohol Addiction Therapeutics Revenue Market Share by Country (2016-2026)

Figure 55. United States Alcohol Addiction Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 56. Canada Alcohol Addiction Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 57. Mexico Alcohol Addiction Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 58. Europe Alcohol Addiction Therapeutics Sales Market Share by Type (2016-2026)

Figure 59. Europe Alcohol Addiction Therapeutics Sales Market Share by Application (2016-2026)

Figure 60. Europe Alcohol Addiction Therapeutics Revenue Market Share by Country (2016-2026)

Figure 61. Germany Alcohol Addiction Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 62. France Alcohol Addiction Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 63. United Kingdom Alcohol Addiction Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 64. Russia Alcohol Addiction Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 65. Italy Alcohol Addiction Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 66. Asia-Pacific Alcohol Addiction Therapeutics Sales Market Share by Type (2016-2026)

Figure 67. Asia-Pacific Alcohol Addiction Therapeutics Sales Market Share by Application (2016-2026)

Figure 68. Asia-Pacific Alcohol Addiction Therapeutics Revenue Market Share by Region (2016-2026)

Figure 69. China Alcohol Addiction Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 70. Japan Alcohol Addiction Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 71. South Korea Alcohol Addiction Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 72. India Alcohol Addiction Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 73. Southeast Asia Alcohol Addiction Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 74. Australia Alcohol Addiction Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 75. South America Alcohol Addiction Therapeutics Sales Market Share by Type (2016-2026)

Figure 76. South America Alcohol Addiction Therapeutics Sales Market Share by Application (2016-2026)

Figure 77. South America Alcohol Addiction Therapeutics Revenue Market Share by Country (2016-2026)

Figure 78. Brazil Alcohol Addiction Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 79. Argentina Alcohol Addiction Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 80. Middle East and Africa Alcohol Addiction Therapeutics Sales Market Share by Type (2016-2026)

Figure 81. Middle East and Africa Alcohol Addiction Therapeutics Sales Market Share by Application (2016-2026)

Figure 82. Middle East and Africa Alcohol Addiction Therapeutics Revenue Market Share by Country (2016-2026)

Figure 83. Turkey Alcohol Addiction Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 84. Saudi Arabia Alcohol Addiction Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 85. UAE Alcohol Addiction Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)

Figure 86. Methodology

Figure 87. Research Process and Data Source